Abstract: An electric rotary machine for an automotive vehicle includes a rotor which is non-rotatably connected to a rotor shaft, and a stator which surrounds the rotor. A casing encloses the rotor and stator, the rotor shaft being rotatably mounted on the casing along an X axis. A stator is carried by the casing, and a stator sleeve is radially arranged between an outer surface of the stator and an inner cylindrical surface of the casing. The stator sleeve is made of an elastic material and is arranged to filter vibrations generated by the stator and resulting from electromagnetic forces present in the stator when the electric rotary machine is in operation. The stator sleeve includes a cooling groove which is intended to be connected to a coolant supply line.

Abstract: A high tenacity regenerated cellulosic fiber is disclosed. Said high tenacity regenerated cellulosic fiber is prepared from a cellulosic raw material, wherein the cellulosic raw material comprises 5-100 wt % of a pre-treated bacterial cellulose having a degree of polymerization in a range of 450-2000; and 0 to 95 wt % of an additional cellulosic material selected from a group consisting of dissolving grade pulp, recycled cotton pulp, reclaimed cellulosic material and a mixture thereof. Said fiber has a tenacity of at least 4.5 grams/denier and elongation of at least 10%, measured in accordance with ASTM D 3822.

Abstract: The invention described herein relates to novel fused pyrimidinediones derivatives of formula (I) which are TRPA (Transient Receptor Potential subfamily A) modulators. In particular, compounds described herein are useful for treating or preventing diseases, conditions and/or disorders modulated by TRPA1 (Transient Receptor Potential subfamily A, member 1). This invention also provides processes for preparing compounds described herein, intermediates used in their synthesis, pharmaceutical compositions thereof, and methods for treating or preventing diseases, conditions and/or disorders modulated by TRPA1.

Abstract: The present invention provides a process for producing low fibrillating cellulose fibers by a dry-jet-wet spinning process wherein cellulose is treated with a solvent containing imidazolium ionic salt in a spinneret maintained at a temperature of 100-120° C. and the spun fibers drawn to the coagulation bath containing ionic salt with the draw ratio less than 5, to produce fibers with fibrillating index less than or equal to 3.

Abstract: The invention described herein relates to novel fused pyrimidinediones derivatives of formula (I) which are TRPA (Transient Receptor Potential subfamily A) modulators. In particular, compounds described herein are useful for treating or preventing diseases, conditions and/or disorders modulated by TRPA1 (Transient Receptor Potential subfamily A, member 1). This invention also provides processes for preparing compounds described herein, intermediates used in their synthesis, pharmaceutical compositions thereof, and methods for treating or preventing diseases, conditions and/or disorders modulated by TRPA1.

Abstract: The invention described herein relates to novel fused pyrimidinediones derivatives of formula (I) which are TRPA (Transient Receptor Potential subfamily A) modulators. In particular, compounds described herein are useful for treating or preventing diseases, conditions and/or disorders modulated by TRPA1 (Transient Receptor Potential subfamily A, member 1). This invention also provides processes for preparing compounds described herein, intermediates used in their synthesis, pharmaceutical compositions thereof, and methods for treating or preventing diseases, conditions and/or disorders modulated by TRPA1.

Abstract: The present invention provides a process for producing low fibrillating cellulose fibers by a dry-jet-wet spinning process wherein cellulose is treated with a solvent containing imidazolium ionic salt in a spinneret maintained at a temperature of 100-120° C. and the spun fibers drawn to the coagulation bath containing ionic salt with the draw ratio less than 5, to produce fibers with fibrillating index less than or equal to 3.

Abstract: A process for manufacturing low-fibrillating cellulosic fibers by a dry-jet-wet spinning process is provided. The cellulose is treated with a specific ionic liquid based solvent to produce the said fibers with fibrillating index less than or equal to (3).

Abstract: The present invention is related to novel furopyrimidinedione derivatives as TRPA (Transient Receptor Potential subfamily A) modulators. In particular, compounds described herein are useful for treating or preventing diseases, conditions and/or disorders modulated by TRPA1 (Transient Receptor Potential subfamily A, member 1). Also provided herein are processes for preparing compounds described herein, intermediates used in their synthesis, pharmaceutical compositions thereof, and methods for treating or preventing diseases, conditions and/or disorders modulated by TRPA1.

Abstract: The invention described herein relates to novel fused pyrimidinediones derivatives of formula (I) which are TRPA (Transient Receptor Potential subfamily A) modulators. In particular, compounds described herein are useful for treating or preventing diseases, conditions and/or disorders modulated by TRPA1 (Transient Receptor Potential subfamily A, member 1). This invention also provides processes for preparing compounds described herein, intermediates used in their synthesis, pharmaceutical compositions thereof, and methods for treating or preventing diseases, conditions and/or disorders modulated by TRPA1.